Evidence map›Paper›PMID 32706823›Full record

ArticlePloS one2020

Prevalence and correlates of active syphilis and HIV co-Infection among sexually active persons aged 15-59 years in Zambia: Results from the Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016.

Hiwote Solomon, Albertina Ngomah Moraes, Daniel B Williams, Arlette Simo Fotso, Yen T Duong, Clement B Ndongmo, Andrew C Voetsch, Hetal Patel, Kathryn Lupoli, James B McAuley and 3 more

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hiwote SolomonDoctor of Public Health Program, School of Public Health, Boston University, Boston, MA, United States of America.ORCID 0000-0001-9125-5217
Albertina Ngomah MoraesMinistry of Health Zambia, Ndeke House, Lusaka, Zambia.
Daniel B WilliamsDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Arlette Simo FotsoDPS University of the Witwatersrand, Johannesburg, South Africa.
Yen T DuongICAP at Columbia University, Mailman School of Public Health, New York, NY, United States of America.
Clement B NdongmoUSAID Global Health Supply Chain Program, United States Agency for International Development, Arlington, Virginia, United States of America.ORCID 0000-0003-0177-8458
Andrew C VoetschDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Hetal PatelDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kathryn LupoliDivision of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
James B McAuleyRush University Medical Center, Chicago, Illinois, United States of America.
Gina MulunduUniversity Teaching Hospital, Lusaka, Zambia.
Webster KasongoTropical Disease Research Centre, Ndola, Zambia.
Lloyd MulengaMinistry of Health Zambia, Ndeke House, Lusaka, Zambia.

Funding

CGH CDC HHS U2G GH001226PEPFAR
6 · The paper itself

Abstract

objectivesThe main objectives of the study are to estimate HIV prevalence, active syphilis prevalence, and correlates of co-infection with HIV in Zambia, among recently sexually active individuals aged 15 to 59 years old.

methodsWe used data from the 2016 Zambia Population-based HIV Impact Assessment (ZAMPHIA), a national household survey that included biomarker testing for HIV and syphilis. Chembio DPP® Syphilis Screen and Confirm Assay was used to distinguish between active and older syphilis infections. This is the first time Chembio DPP® has been used in a national survey. Log-binominal modelling was utilized to understand the risk of acquiring HIV/active syphilis co-infection using select socio-demographic and sexual behavior variables. Multivariable analysis compared those with co-infection and those with no infection. All reported results account for the complex survey design and are weighted.

resultsA total of 19,114 individuals aged 15-59 years responded to the individual interview and had a valid syphilis and/or HIV test. The prevalence for those sexually active in the 12 months preceding ZAMPHIA 2016 was 3.5% and 13% for active syphilis and HIV, respectively. The prevalence of HIV/active syphilis co-infection was 1.5%. Factors associated with higher prevalence of co-infection versus no infection among females included, but were not limited to, those living in urban areas (adjusted prevalence ratio (aPR) = 3.0, 95% CI = 1.8, 4.8), those had sexual intercourse before age 15 years (aPR = 1.8, 95% CI = 1.1, 2.9), and those who had two or more sexual partners in the 12 months preceding the survey (aPR = 2.7, 95% CI = 1.6, 4.7).

conclusionThese findings show high prevalence for both mono-infection with HIV and syphilis, as well as co-infection with HIV/active syphilis in Zambia. There is a need for better screening and partner services, particularly among those engaging in high-risk sexual behaviors (e.g., engaging in transactional sex).

Indexed as

AdolescentAdultCoinfectionCross-Sectional StudiesFemaleHealth Risk BehaviorsHIV-1HIV InfectionsHumansMaleMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesSyphilisUnsafe Sex

Identifiers

PMID32706823
PMCPMC7380641

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.